Mon, 09.10.2017 @09:00
in Hoffmann-La Roche
[add to iCal]
categories:
About the event
The Roche Science Day gives you the opportunity to gain an exclusive insight into how Roche Pharma Research and Development (Roche pRED) drives innovation. You will meet highly recognized researchers at the Basel headquarters and experience Roche pRED first hand.
Roche generously extended an invitation to the D-BSSE. The registration for D-BSSE members runs through our website, and we will forward the registrations to Roche. Registration deadline for this event is Wednesday, the 4th of October.
You can find the detailed agenda below:
08.30 – 09.00 Registration and Welcome
09.00 – 09.10 Welcome and Introduction
Dr. John C. Reed, Global Head of Pharma Research & Early Development (pRED) and Member of the Enlarged Corporate Executive Committee
09.10 – 09.20 This is pRED
Dr. Matthias Nettekoven, Principal Scientist, Medicinal Chemistry
09.20 – 09.50 Disease Therapeutics Areas (DTAs)
- 09.20 – 09.30 Brain Shuttle
Dr. Per-Ola Freskgard, Expert Scientist Neuroscience Discovery - 09.30 – 09.40 HBV LNA program
Dr. Timothy Tellinghuisen, Discovery Area Leader, ID Discovery group, I3 DTA - 09.40 – 09.50 Oncology
Dr. James Bischoff, Global Head of Molecular Targeted Therapy – Discovery Oncology
09.50 – 10.10 Large molecule drug discovery
Dr. Stefan Weigand, Global Head Large Molecule Research
10.10 – 10.30 Small molecule drug discovery
- 10.10 – 10.20 Hit finding / Lead identification
Dr. Sara Cortese, Global Head of Chemical Biology - 10.20 – 10.30 Lead optimization
Dr. Patrick Schnider, Expert Scientist, Medicinal Chemistry
10.30 – 10.50 Oligonucleotide drug discovery
Dr. Bo Hansen (MBA), Global Head of RNA Therapeutics and General Manager
of Roche Innovation Center Copenhagen
10.50 – 11.05 Break
11.05 – 11.10 Setting the scence
Dr. Matthias Nettekoven, Principal Scientist, Medicinal Chemistry
11.10 – 11.30 Technical development of Small molecules and Oligonucleotide
Dr. Remo Gamboni, Global Head preclinical CMC
11.30 – 11.50 Drug metabolism/Pharmacokinetics
Dr. Lisa Benincosa, Global Head DMPK Development
11.50 – 12.10 Drug safety / toxicology
Dr. Annie Moisan, Principal Scientist at Roche Pharmaceuticals
12.10 – 12.30 Modelling / systems pharmacology
Dr. Thiery Lave, Head DMPK and TOX Project Leaders and
Modeling and Simulation
12.30 – 12.50 Biomarkers
Dr. Corinne Solier, Global Head of Translational Technologies and Bioinformatics
12.50 – 13.40 Networking Lunch (with Roche colleagues from pRED)
13.40 – 14.00 Partnering / Business development
Dr. Maria Bobadilla (MD), Innovation Partnering, Senior Director
14.00 – 14.30 Pathway studies in Pharma: A personal guide
Dr. Johannes Mosbacher, Business Interface Officer
BOOKINGS
Information about the booking process on the "Next Events" tab!Bookings are closed for this event.